Recent advances in understanding the biology of diabetes-associated bladder complications and novel therapy

BJU International

Volumn 95, Issue 6, 2005, Pages 733-738

  Yoshimura, Naoki ^a   Chancellor, Michael B ^b,e   Andersson, Karl Erik ^c   Christ, George J ^d  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b MCGOWAN INSTITUTE FOR REGENERATIVE MEDICINE   (United States)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

^d WAKE FOREST SCHOOL OF MEDICINE   (United States)

^e NONE   (United States)

Author keywords

Detrusor; Diabetes mellitus; Nerve growth factor; Smooth muscle; Urothelium

Indexed keywords

BLADDER CAPACITY; BLADDER DISTENSION; BLADDER DYSFUNCTION; BLADDER FILLING; CONFERENCE PAPER; CYSTOMETRY; DETRUSOR MUSCLE; DIABETES MELLITUS; DIABETIC CYSTOPATHY; DIABETIC NEUROPATHY; FEMALE; HUMAN; LIPID COMPOSITION; MALE; MICTURITION; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; RESIDUAL URINE; STREPTOZOCIN DIABETES; URETHRA OBSTRUCTION; URINE INCONTINENCE;

DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; HUMANS; MUSCULAR DISEASES; NERVOUS SYSTEM DISEASES; URINARY BLADDER; URINARY BLADDER DISEASES;

EID: 17444429596     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2005.05392.x     Document Type: Conference Paper

References (41)

1. Mokdad AH, Bowman BA, Ford ES, Vinicor F, Marks JS, Koplan JP. The continuing epidemics of obesity and diabetes in the United States. JAMA 2001; 286: 1195-200
2. Paro M, Prosdocimi M, Sima AA. Gangliosides improve urinary bladder dysfunction in experimental diabetic autonomic neuropathy. Pharmacol Res 1990; 22: 125-6
3. Kidlacz EM, Gerald MC, Wallace JL Effects of diabetes and diuresis on contraction and relaxation mechanisms in rat urinary bladder. Diabetes 1989; 38: 278-84
4. Steers WD, Mackway AM, Ciambotti J, de Groat WC. Effect of streptozotocin-induced diabetes on bladder function in the rat. J Urol 1990; 143: 1032-6
5. Chancellor MB, Blaivas JG. Multiple sclerosis and diabetic neurogenic bladder. In Blaivas JG, Chancellor MB eds, Atlas of Urodynamics. Chapter 15. Philadelphia: Williams & Wilkins, 1996: 183-91
6. Goldstein I, Siroky MB, Krane RJ. Impotence in diabetes mellitus. In Krane RJ, Siroky MB, Goldstein I eds Male Sexual Dysfunction. Boston, MA: Little, Brown, 1983: 77-86
7. Ellenberg M. Development of urinary bladder dysfunction in diabetes mellitus. Ann Intern Med 1980; 92: 321
8. Frimodt-Moller C. Diabetic cystopathy I. A clinical study on the frequency of bladder dysfunction in diabetics. Dan Med Bull 1976; 23: 267-72
9. Ueda T, Yoshimura N, Yoshida O. Diabetic cystopathy: Relationship to autonomic neuropathy detected by sympathetic skin response. J Urol 1997; 157: 580-4
10. Kaplan SA, Te AE, Blaivas JG. Urodynamic findings in patients with diabetic cystopathy. J Urol 1995; 153: 342-4
11. Andersen JT, Bradley WE. Early detection of diabetic visceral neuropathy. An electrophysiologic study of bladder and urethral innervation. Diabetes 1976; 25: 1100-5
12. Andersen JT, Bradley WE. Abnormalities of bladder innervation in diabetes mellitus. Urology 1976; 7: 442-8
13. Sasaki K, Yoshimura N, Chancellor MB. Implications of diabetes mellitus in urology. Urol Clin North Am 2003; 30: 1-12
14. Paro M, Prashar A, Prosdocimi M, Cherian PV, Fiori MG, Sima AA. Urinary bladder dysfunction in the BB/W diabetic rat. effect of ganglioside treatment on functional and structural alterations. J Urol 1994; 151: 781-6
15. Pinna C, Zanardo R, Puglisi L. Prostaglandin-release impairment in the bladder epithelium of streptozotocin-induced diabetic rats. Eur J Pharmacol 2000; 388: 267-73
16. Pitre DA, Ma T, Wallace LJ, Bauer JA. Time-dependent urinary bladder remodeling in the streptozotocin-induced diabetic rat model. Acta Diabetol 2002; 39: 23-7
17. Mimata H, Wheeler MA, Fukumoto Y et al. Enhancement of muscarinic receptor-coupled phosphatidyl inositol hydrolysis in diabetic bladder. Mol Cell Biochem 1995; 152: 71-6
18. Kanda M, Eto K, Tanabe N, Sugiyama A, Hashimoto K, Ueno A. Effect of ONO-2235, an aldose reductase inhibitor, on muscarinic receptors and contractile response of the urinary bladder in rats with streptozotocin-induced diabetes. Jpn J Pharmacol 1997; 73: 221-8
19. Malmgren A, Andersson PO, Uvelius B. Bladder function in rats with short- and long-term diabetes; effects of age and muscarinic blockade. J Urol 1989; 142: 1608-14
20. 2muscaranic receptor of the urinary bladder in diabetic rats. Neurosci Let 2002; 330: 21-4
21. 1- adrenoceptors in experimental diabetes. European J Pharmacol 2003; 467: 191-5
22. Longhurst PA, Kauer J, Levin RM. The ability of insulin treatment to reverse or prevent the changes in urinary bladder function caused by streptozotocin-induced diabetes mellitus. General Pharmacol 1991; 22: 305-11
23. Waring JV, Wendt IR. Effects of streptozotocin-induced diabetes mellitus on intracellular calcium and contraction of longitudinal smooth muscle from rat urinary bladder. J Urol 2000; 163: 323-30
24. Tammela TL, Briscoe JA, Levin RM, Longhurst PA. Factors underlying the increased sensitivity to field stimulation of urinary bladder strips from streptozotocin-induced diabetic rats. Br J Pharmacol 1994; 113: 195-203
25. Belis JA, Curley RM, Wagner CH, Murty VN, Winter SJ, Rohner TJ. Neurogenic function of the diabetic rat bladder: alteration by calcium channel effectors. Pharmacology 1991; 43: 273-81
26. Bezuijen MWF, Levendusky MC, Longhurst PA. Functional response of bladder strips from streptozotocin diabetic rats depends on bladder mass. J Urol 2003; 169: 2397-401
27. Longhurst PA, Levendusky MC, Bezuijen MW. Diabetes mellitus increases the rate of development of decompensation in rats with outlet obstruction. J Urol 2004; 171: 933-7
28. Hashitani H, Suzuki H. Altered electrical properties of bladder smooth muscle in streptozotocin-induced diabetic rats. Br J Urol 1996; 77: 798-804
29. Poladia DP, Bauer JA. Early cell-specific changes in nitric oxide synthases, reactive nitrogen species formation, and ubiquitinylation during diabetes-related bladder remodeling. Diabetes Metab Res Rev 2003; 19: 313-9
30. Longhurst PA. Urinary bladder function 6 months after the onset of diabetes in the spontaneously diabetic BB rat. J Urol 1991; 145: 417-22
31. Apfel SC. Neurotrophic factors and diabetic peripheral neuropathy. Eur Neurol 1999; 41 (Suppl): 27-34
32. Van Poppel H, Stessens R, Van Damme B, Carton H, Baert L. Diabetic cystopathy. Neuropathological examination of urinary bladder biopsy. Eur Urol 1988; 15: 128-31
33. Sasaki K, Chancellor MB, Phelan MW et al. Diabetic cystopathy correlates with long-term decrease in nerve growth factor (NGF) levels in the bladder and lumbosacral dorsal root ganglia. J Urol 2002; 168: 1259-64
34. Goins WF, Yoshimura N, Phelan MW, de Groat WC, Glorioso JC, Chancellor MB. Herpes simplex virus mediated nerve growth factor expression in bladder and afferent neurons: Potential treatment for diabetic bladder dysfunction. J Urol 2001; 165: 1748-54
35. Sasaki K, Chancellor MB, Goins WF et al. Gene therapy using replication defective herpes simplex virus (HSV) vectors expressing nerve growth factor (NGF) in a rat model of diabetic cystopathy. Diabetes 2004; 53: 2723-30
36. Vlaskovska M, Kasakov L, Rong W et al. P2X3 knock-out mice reveal a major sensory role for urothelially released ATP. J Neurosci 2001; 21: 5670-7
37. Birder LA, Nealen ML, Kiss S et al. Beta-adrenoceptor agonists stimulate endothelial nitric oxide synthase in rat urinary bladder urothelial cells. J Neurosci 2002; 15: 8063-70
38. Avelino A, Cruz C, Nagy I, Cruz F. Vanilloid receptor 1 expression in the rat urinary tract. Neuroscience 2002; 109: 787-98
39. Birder LA, Nakamura Y, Kiss S et al. Altered urinary bladder function in mice lacking the vanilloid receptor TRPV1. Nat Neurosci 2002; 5: 856-60
40. Zenser TV, Thomasson DL, Davis BB. Characteristics of bradykinin and TPA increases in the PGE2 levels of human urothelial cells. Carcinogenesis 1988; 9: 1173-7
41. Geerlings SE, Meiland R, van Lith EC, Brouwer EC, Gaastra W, Hoepelman AI. Adherence of type 1-fimbriated Escherichia coli to uroepithelial cells: more in diabetic women than in control subjects. Diabetes Care 2002; 25: 1405-9